Saliva-based COVID-19 test to be submitted for emergency use authorization with the FDA
Developed by a URI professor, the QuantiCOVID-19 tests are less invasive and less expensive than PCR tests, are more sensitive than rapid tests, and use minimal scientific equipment, making it ideal for college campuses and developing countries.